carbamates has been researched along with Allergic Encephalomyelitis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "PL mice with myelin basic protein on Days 0 and 2, and mice received twice daily oral dosing of SNJ 1945 from Day 9 until sacrificing (Day 26)." | 5.43 | Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. ( Azuma, M; Banik, NL; Inoue, J; Ray, SK; Rohrer, B; Samantaray, S; Smith, AW; Wheless, L, 2016) |
| " Here, we show that oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two pronged effect via anti-inflammation and protection against neurodegeneration." | 5.40 | Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. ( Azuma, M; Banik, NL; Beeson, C; Haque, A; Inoue, J; Smith, A; Trager, N; Wallace Iv, G, 2014) |
| "PL mice with myelin basic protein on Days 0 and 2, and mice received twice daily oral dosing of SNJ 1945 from Day 9 until sacrificing (Day 26)." | 1.43 | Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. ( Azuma, M; Banik, NL; Inoue, J; Ray, SK; Rohrer, B; Samantaray, S; Smith, AW; Wheless, L, 2016) |
| " Here, we show that oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two pronged effect via anti-inflammation and protection against neurodegeneration." | 1.40 | Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. ( Azuma, M; Banik, NL; Beeson, C; Haque, A; Inoue, J; Smith, A; Trager, N; Wallace Iv, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manterola, A | 1 |
| Bernal-Chico, A | 1 |
| Cipriani, R | 1 |
| Ruiz, A | 1 |
| Pérez-Samartín, A | 1 |
| Moreno-Rodríguez, M | 1 |
| Hsu, KL | 1 |
| Cravatt, BF | 1 |
| Brown, JM | 1 |
| Rodríguez-Puertas, R | 1 |
| Matute, C | 1 |
| Mato, S | 1 |
| Trager, N | 1 |
| Smith, A | 1 |
| Wallace Iv, G | 1 |
| Azuma, M | 2 |
| Inoue, J | 2 |
| Beeson, C | 1 |
| Haque, A | 1 |
| Banik, NL | 2 |
| Rosenberger, TA | 1 |
| Wen, J | 1 |
| Ribeiro, R | 1 |
| Tanaka, M | 1 |
| Zhang, Y | 1 |
| Smith, AW | 1 |
| Rohrer, B | 1 |
| Wheless, L | 1 |
| Samantaray, S | 1 |
| Ray, SK | 1 |
5 other studies available for carbamates and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Topics: Animals; Benzoates; Biphenyl Compounds; Brain; Calcium; Carbamates; Cells, Cultured; Encephalomyelit | 2018 |
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
Topics: Animals; Blotting, Western; Calpain; Carbamates; Cell Proliferation; Cell Separation; Cysteine Prote | 2014 |
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Topics: Animals; Calpain; Carbamates; Cysteine Proteinase Inhibitors; Encephalomyelitis, Autoimmune, Experim | 2014 |
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Carbamates; Encephalomyelitis, Autoimmune, Ex | 2015 |
Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.
Topics: Animals; Calpain; Carbamates; Cell Death; Electroretinography; Encephalomyelitis, Autoimmune, Experi | 2016 |